How Big Is Indonesia's Chance to Secure COVID-19 Drug Supplies?

Summary

The government is exploring the possibility of securing decent supplies of several new COVID-19 drugs, including Molnupiravir produced by Merck & Co, a US-based pharmaceutical company. The Health Minister, Budi Gunadi Sadikin, revealed that he had been approaching a number of global pharmaceutical manufacturers producing COVID-19 drugs. The ministry will also team up with the Food and Drug Monitoring Agency (BPOM) and state-owned hospitals to review them.

Apart from Molnupiravir, several new drugs being explored are those developed by the United States pharmaceutical company Eli Lilly and Celltrion Inc from South Korea. "We have approached the manufacturer and even planned to start clinical trials," Budi revealed on Monday (10/4). He also said that several types of drugs were being tested, from monoclonal antibodies such as Regeneron to other antiviral drugs. "Hopefully, by the end of this year, we will know which drugs are suitable for our society," he said.

Start your free trial.

If you would like to get a 30-day free unlimited access to all of our insights, please click “Start free trial” button below. If you already have an account, please login.

What do subscribers receive?

As a subscriber, you’ll receive daily insights, weekly business digests, and quarterly industrial reports.

What kind of pieces will i get?

In-depth reports on assumption and impact analysis, as well as update and trends mapping, written by our credible and experienced analysts.

And, there is something else…

Enjoy a 30-day free trial, on us. Feel free to contact us with any additional questions you have.